Get the Stockscreener App
71.24
1.41%
0.99
After Hours:
70.70
-0.54
-0.76%
Overview
News
Price History
Option Chain
Why AZN Down?
Discussions
Forecast
Stock Split
Dividend History
Astrazeneca PLC Stock (AZN) Latest News
ROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN - GlobeNewswire Inc.
AstraZeneca PLC ADR underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Shareholders that lost money on AstraZeneca PLC(AZN) should - GlobeNewswire
Deadline Alert: AstraZeneca PLC (AZN) Investors Who Lost - GlobeNewswire
AstraZeneca and GSK put spotlight on pharma as results loom - Proactive Investors UK
Investors in AstraZeneca PLC Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your RightsAZN - Stockhouse Publishing
AZN LAWSUIT ALERT: The Gross Law Firm Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire
AstraZeneca (AZN) to Release Quarterly Earnings on Thursday - MarketBeat
2025-01-29 | Shareholders that lost money on AstraZeneca PLC (AZN) should contact Levi & Korsinsky about pending Class ActionAZN | NDAQ:AZN | Press Release - Stockhouse Publishing
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
AstraZeneca's SWOT analysis: pharma giant's stock poised for growth amid challenges - Investing.com
Class Action Filed Against AstraZeneca PLC (AZN)February 21, 2025 Deadline to JoinContact Levi & Korsinsky - Stockhouse Publishing
Levi & Korsinsky Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming DeadlineAZN - Stockhouse Publishing
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca - GlobeNewswire
Should AstraZeneca Stock Be in Your Portfolio Pre-Q4 Earnings? - Yahoo Finance
Swedbank AB Purchases 125,600 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Lost Money on AstraZeneca PLC(AZN)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - Stockhouse Publishing
Iams Wealth Management LLC Increases Stake in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Here's Why Astrazeneca (AZN) is a Strong Value Stock - Yahoo Finance
Orca Wealth Management LLC Invests $4.53 Million in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Russ Mould: what to expect when AstraZeneca and GSK report next week - AJ Bell
AstraZeneca's (AZN) "Buy" Rating Reaffirmed at Berenberg Bank - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming DeadlinesAZN - PR Newswire
Global markets live: Nvidia, Microsoft, Lockheed Martin, AstraZeneca, Airbus… - Marketscreener.com
FDA Approves AstraZeneca, Daiichi Sankyo's Enhertu For Certain Type Of Breast Cancer Patients - Benzinga
AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Shareholders of AstraZeneca PLC Should Contact The Gross Law Firm Before February 21, 2025 to Discuss Your RightsAZN - The Malaysian Reserve
AstraZeneca Scores US Regulatory Approval for Breast Cancer Treatment Enhertu -January 28, 2025 at 06:01 am EST - Marketscreener.com
Blue Trust Inc. Buys 7,686 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
AstraZeneca: FDA extends approval of Enhertu -January 28, 2025 at 04:32 am EST - Marketscreener.com
Dynamic Advisor Solutions LLC Cuts Stake in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
AstraZeneca, Daiichi’s Drug Wins Wider Use in Breast Cancer Patients - Bloomberg
ROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC - GlobeNewswire
AstraZeneca, Daiichi Sankyo's Breast Cancer Treatment Wins US Approval -January 27, 2025 at 11:18 pm EST - Marketscreener.com
Chronic Pulmonary Infections Pipeline 2024: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Teva Pharma, Merck, F. Hoffmann-La Roche, Novartis, GlaxoSmithKline, AstraZeneca - The Globe and Mail
AstraZeneca PLC ADR rises Monday, outperforms market - MarketWatch
AstraZeneca rises Monday, outperforms market - MarketWatch
2025-01-27 | AstraZeneca PLC Sued for Securities Law ViolationsContact Levi & Korsinsky Before February 21, 2025 to Discuss Your RightsAZN | NDAQ:AZN | Press Release - Stockhouse Publishing
AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit Filed by The Rosen Law Firm - PR Newswire
2025-01-26 | AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your RightsAZN | NDAQ:AZN | Press Release - Stockhouse Publishing
AstraZeneca PLC (NASDAQ:AZN) Shares Acquired by Asio Capital LLC - MarketBeat
AstraZeneca - Britannica
Goelzer Investment Management Inc. Buys 22,983 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Encompass More Asset Management Makes New $314,000 Investment in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Dakota Wealth Management Sells 6,806 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Class Action Filed Against AstraZeneca PLC (AZN) Seeking Recover - GuruFocus.com
ROSEN, THE FIRST FILING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before - The Bakersfield Californian
AstraZeneca PLC's (LON:AZN) Popularity With Investors Is Clear - Simply Wall St
AstraZeneca Canadian investment to drive R&D growth -January 24, 2025 at 12:01 pm EST - Marketscreener.com
AstraZeneca rises Friday, outperforms market - MarketWatch
Lowey Dannenberg Notifies AstraZeneca PLC (“AstraZeneca” or - GlobeNewswire
Here's Why Astrazeneca (AZN) is a Strong Growth Stock - Yahoo Finance
AstraZeneca Sees Canada As Land Of Opportunity With $570m Investment - News & Insights
AstraZeneca To Pump $570 Million Into Canada, Driving Expansion, Job Growth - Benzinga
AstraZeneca PLC Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsAZN - The Eastern Progress Online
Class Action Filed Against AstraZeneca PLC (AZN) Seeking Recovery for InvestorsContact Levi & Korsinsky - Morningstar
AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by SG Americas Securities LLC - MarketBeat
AstraZeneca: $570 million invested in Canada -January 24, 2025 at 03:52 am EST - Marketscreener.com
AstraZeneca announces new $820 million investment in Canada - BNN Bloomberg
AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
AstraZeneca to Invest C$820 Million to Move to Larger Toronto Office -January 23, 2025 at 03:10 pm EST - Marketscreener.com
AstraZeneca to invest $820-million in Ontario life sciences sector, says it will create 700 jobs - The Globe and Mail
AstraZeneca to invest $570M in Canada (AZN:NASDAQ) - Seeking Alpha
AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery - Quantisnow
AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery – Company AnnouncementFT.com - Financial Times
AstraZeneca to invest $570m in Canada, creating 700 new jobs By Investing.com - Investing.com South Africa
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):